Vision is the most dominant of our senses. Yet, 2.2 billion people suffer from vision impairments of which 50% could be prevented or cured. And this number is growing due to our ageing populations and modern lifestyles. At the same time healthcare systems have limited resources. Eye care lags behind in the digital transformation and novel technology is not fully leveraged. As a result, people lose vision that do not have to. We combine AI algorithms, virtual reality and cloud computing to build the next generation systems to test visual function. We improve workflow efficiency and provide deeper clinical insight into eye diseases. To leverage these technologies fully, we take a disease-centric approach. The first condition we target is glaucoma. We address the large unmet need for more efficient and effective monitoring of 80M patients worldwide.
Vision is the most dominant of our senses. Yet, 2.2 billion people suffer from vision impairments of which 50% could be prevented or cured. And this number is growing due to our ageing populations and modern lifestyles. At the same time healthcare systems have limited resources. Eye care lags behind in the digital transformation and novel technology is not fully leveraged. As a result, people lose vision that do not have to. We combine AI algorithms, virtual reality and cloud computing to build the next generation systems to test visual function. We improve workflow efficiency and provide deeper clinical insight into eye diseases. To leverage these technologies fully, we take a disease-centric approach. The first condition we target is glaucoma. We address the large unmet need for more efficient and effective monitoring of 80M patients worldwide.
Company Information
- Industry
- Company Type
- Public Company
- Founded
- 2022
- Employee Range
- 11-50
- Revenue Range
- Not available
Location
- Address
- City
- Freiburg Im Breisgau
- Region
- Baden-Württemberg
- Postal Code
- Country
- Germany